152 related articles for article (PubMed ID: 20170663)
1. Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice.
Streicher JM; Kamei K; Ishikawa TO; Herschman H; Wang Y
J Mol Cell Cardiol; 2010 Jul; 49(1):88-94. PubMed ID: 20170663
[TBL] [Abstract][Full Text] [Related]
2. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
LaPointe MC; Mendez M; Leung A; Tao Z; Yang XP
Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1416-24. PubMed ID: 14670812
[TBL] [Abstract][Full Text] [Related]
4. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
5. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
6. Protease activated receptor-2 contributes to heart failure.
Antoniak S; Sparkenbaugh EM; Tencati M; Rojas M; Mackman N; Pawlinski R
PLoS One; 2013; 8(11):e81733. PubMed ID: 24312345
[TBL] [Abstract][Full Text] [Related]
7. Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2.
Papanicolaou KN; Streicher JM; Ishikawa TO; Herschman H; Wang Y; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):196-209. PubMed ID: 20399788
[TBL] [Abstract][Full Text] [Related]
8. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Li HL; Zhuo ML; Wang D; Wang AB; Cai H; Sun LH; Yang Q; Huang Y; Wei YS; Liu PP; Liu DP; Liang CC
Circulation; 2007 Apr; 115(14):1885-94. PubMed ID: 17389268
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
Belge C; Hammond J; Dubois-Deruy E; Manoury B; Hamelet J; Beauloye C; Markl A; Pouleur AC; Bertrand L; Esfahani H; Jnaoui K; Götz KR; Nikolaev VO; Vanderper A; Herijgers P; Lobysheva I; Iaccarino G; Hilfiker-Kleiner D; Tavernier G; Langin D; Dessy C; Balligand JL
Circulation; 2014 Jan; 129(4):451-62. PubMed ID: 24190960
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
[TBL] [Abstract][Full Text] [Related]
11. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
[TBL] [Abstract][Full Text] [Related]
12. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
13. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
[TBL] [Abstract][Full Text] [Related]
14. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling.
Zhao X; Balaji P; Pachon R; Beniamen DM; Vatner DE; Graham RM; Vatner SF
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2451-9. PubMed ID: 26338300
[TBL] [Abstract][Full Text] [Related]
16. JDP2 overexpression provokes cardiac dysfunction in mice.
Heger J; Bornbaum J; Würfel A; Hill C; Brockmann N; Gáspár R; Pálóczi J; Varga ZV; Sárközy M; Bencsik P; Csont T; Török S; Kojonazarov B; Schermuly RT; Böngler K; Parahuleva M; Ferdinandy P; Schulz R; Euler G
Sci Rep; 2018 May; 8(1):7647. PubMed ID: 29769710
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FNTB and the activation of Ras induce hypertrophy and promote apoptosis and autophagic cell death in cardiomyocytes.
Ding J; Chen YX; Chen Y; Mou Y; Sun XT; Dai DP; Zhao CZ; Yang J; Hu SJ; Guo X
J Cell Mol Med; 2020 Aug; 24(16):8998-9011. PubMed ID: 32579303
[TBL] [Abstract][Full Text] [Related]
18. Conditional cardiac overexpression of S100A6 attenuates myocyte hypertrophy and apoptosis following myocardial infarction.
Tsoporis JT; Izhar S; Desjardins JF; Leong-Poi H; Parker TG
Curr Pharm Des; 2014; 20(12):1941-9. PubMed ID: 23844739
[TBL] [Abstract][Full Text] [Related]
19. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
20. Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
Yurista SR; Matsuura TR; Silljé HHW; Nijholt KT; McDaid KS; Shewale SV; Leone TC; Newman JC; Verdin E; van Veldhuisen DJ; de Boer RA; Kelly DP; Westenbrink BD
Circ Heart Fail; 2021 Jan; 14(1):e007684. PubMed ID: 33356362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
